[纳尔德美丁 (Rizmoic®) 用于治疗阿片类药物引起的便秘]
1(1) Directeur du LAC (Leuvens Algologisch Centrum), le centre d'algologie (clinique de la douleur) de la KUL, Louvain, Belgique.
Revue medicale de Liege
|November 13, 2025
概括
阿片类药物引起的便秘 (OIC) 是慢性疼痛治疗的常见副作用. 当标准治疗无效时,纳尔德美丁为患有OIC的患者提供了一个新的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 疼痛管理 疼痛管理
背景情况:
- 阿片类药物诱导的便秘 (OIC) 是接受阿片类药物治疗慢性疼痛的患者经常出现的不良反应.
- OIC显著降低了患者的生活质量,并可能使疼痛管理复杂化.
- 标准OIC治疗可能对所有患者来说都不够.
研究的目的:
- 引入纳尔德美丁作为治疗治疗阿片类药物诱导便秘的替代方案.
- 突出外围作用的μ-阿片类受体对抗剂在OIC管理中的作用.
主要方法:
- 纳尔德美丁是一种选择性外围作用的μ-阿片类受体对抗剂.
- 这种治疗方法针对胃肠道中的阿片类受体,而不会影响中央止痛作用.
主要成果:
- 纳尔德美丁为OIC患者提供了一个选择,这些患者对传统疗法没有反应.
- 在慢性疼痛治疗期间,OIC的有效管理对于患者的整体健康至关重要.
结论:
- 纳尔德美丁是治疗阿片类药物引起的便秘的宝贵补充.
- 解决OIC是综合性慢性疼痛管理策略的组成部分.
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
602
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
602
Drugs for Treatment of Diarrhea-Predominant IBS
612
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
612
Drugs for Treatment of Constipation-Predominant IBS
686
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
686
Drugs Affecting GI Tract Motility: Other Laxatives
1.0K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.0K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
517
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
517
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K


